Clorox (CLX) Tops Q3 EPS by 6c; Trims FY EPS Outlook, Sees Sales at Top End
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Dow tick higher as investors weigh Mideast negotiations
- Oil falls after US-Iran talks signal easing supply risks
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Clorox Reports Q3 Fiscal Year 2018 Results, Updates Fiscal Year 2018 Outlook
May 2, 2018 6:30 AM EDTOAKLAND, Calif., May 2, 2018 /PRNewswire/ --Â The Clorox Company (NYSE: CLX) reported sales growth of 3 percent and diluted net earnings per share from continuing operations (diluted EPS) of $1.37, an increase of 5 percent, for its third quarter of fiscal year 2018, which ended March 31, 2018.
"We delivered solid sales growth of 3 percent, with gains in all U.S. segments and in our International segment, behind our 2020 Strategy,"Â said Chairman and CEO Benno Dorer. "Notably, we delivered these results on top of 4 percent sales growth in the year-ago quarter. Our focus on providing superior value to consumers... More
